Drug Price Trends for ZILEUTON ER

Average Pharmacy Cost for ZILEUTON ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ZILEUTON ER 600 MG TABLET	64380-0189-01	4.36279	EACH	2025-03-19
ZILEUTON ER 600 MG TABLET	64980-0206-12	4.36279	EACH	2025-03-19
ZILEUTON ER 600 MG TABLET	31722-0044-12	4.36279	EACH	2025-03-19
ZILEUTON ER 600 MG TABLET	68180-0169-16	4.36279	EACH	2025-03-19
ZILEUTON ER 600 MG TABLET	72603-0246-01	4.36279	EACH	2025-03-19
ZILEUTON ER 600 MG TABLET	31722-0044-12	4.54297	EACH	2025-02-19

Market Analysis and Price Projections for Zileuton ER

Introduction to Zileuton ER

Zileuton ER, a member of the leukotriene modifiers drug class, is commonly used for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. It is available in the form of extended-release tablets, typically 600 mg.

Global Market Size and Growth

The global Zileuton market was valued at approximately USD 1.5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. This growth is driven by the increasing prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and rising awareness about treatment options[1].

Market Drivers

Several factors are driving the growth of the Zileuton market:

Increasing Prevalence of Respiratory Diseases

The global rise in respiratory diseases is a significant driver. As the number of patients with asthma and COPD increases, so does the demand for effective treatments like Zileuton ER[1][3].

E-Commerce and Direct-to-Consumer Channels

The growing reliance on e-commerce and direct-to-consumer (D2C) channels in the pharmaceutical sector is expanding the customer base for Zileuton ER. These channels offer convenience, accessibility, and targeted marketing opportunities, which are crucial for pharmaceutical companies[1].

Advances in Healthcare Infrastructure

Improvements in healthcare facilities and treatment options also contribute to the market growth. Well-established healthcare systems, particularly in North America and Europe, support the adoption of leukotriene modifiers like Zileuton ER[3].

Market Segmentation

By Product

The Zileuton market is segmented by product type, with extended-release tablets being the primary form. This formulation is preferred due to its convenience and efficacy in managing asthma symptoms[1].

By Application

The market is also segmented by application, with the largest share held by hospitals and drug stores. These settings are critical for the distribution and administration of Zileuton ER[1].

By Geography

North America, particularly the United States, is expected to play a pivotal role in the market's development. Europe and the Asia-Pacific region are also significant markets, driven by high adoption rates of advanced technologies and the presence of major industry players[1][3].

Key Manufacturers

Several key manufacturers are driving the Zileuton market:

Prasco

Chiesi

Lupin

Endo International

Rising

These companies are investing heavily in research and development and are expanding their product offerings through strategic initiatives[1].

Price Analysis

The cost of Zileuton ER can vary significantly depending on the pharmacy and the presence of generic alternatives.

Brand Name Prices

The brand name version, Zyflo CR, costs around $3,968 for a supply of 120 tablets (600 mg each)[5].

Generic Prices

The generic version, launched by Lupin, is priced lower, around $2,839 for a supply of 120 tablets (600 mg each)[2].

Price Projections

Given the market growth and increasing demand, here are some key price projections:

Short-Term Projections

In the short term, prices are expected to remain relatively stable due to the balance between brand and generic offerings. However, any changes in regulatory policies or significant advancements in treatment options could impact pricing.

Long-Term Projections

Over the long term, the prices of Zileuton ER are likely to be influenced by the overall growth of the leukotriene modifiers market. With a projected CAGR of 5.3% for the global leukotriene modifiers market from 2023 to 2033, prices may adjust to reflect increased demand and competition[3].

Competitive Landscape

The competitive landscape of the Zileuton market is intense, with several major pharmaceutical companies vying for market share. Companies like Lupin, Chiesi, and Endo International are focusing on strategic initiatives such as product development, direct-to-consumer marketing, and expanding their distribution networks[1].

Market Research and Strategic Planning

Market research reports play a crucial role in strategic planning for businesses in the Zileuton market. These reports help in understanding market trends, identifying potential risks, and gaining insights into competitors' strategies. For investors, these reports provide critical data for making informed decisions by highlighting market forecasts and growth potential[1].

Regional Outlook

North America

North America, particularly the United States, is expected to continue its dominance in the Zileuton market. The high incidence of respiratory diseases and the presence of major pharmaceutical companies drive this growth[1][3].

Europe

Europe is also expected to experience significant growth, although the presence of large pharmaceutical companies like GSK may influence market dynamics[3].

Asia-Pacific

The Asia-Pacific region is anticipated to grow at a high CAGR due to the rising need for long-term control of respiratory diseases and the expansion of healthcare infrastructure[3].

Key Takeaways

• The global Zileuton market is projected to grow at a CAGR of 5.2% from 2023 to 2030.
• The market is driven by the increasing prevalence of respiratory diseases and the growing reliance on e-commerce and D2C channels.
• North America, particularly the United States, will continue to be a key region for market growth.
• The prices of Zileuton ER vary between brand and generic versions, with generic options offering more affordability.
• Market research reports are essential for strategic planning and risk management in the Zileuton market.

FAQs

What is the current market size of the global Zileuton market?

The global Zileuton market was valued at approximately USD 1.5 billion in 2023[1].

What is the projected growth rate of the Zileuton market?

The Zileuton market is projected to expand at a CAGR of 5.2% from 2023 to 2030[1].

Which regions are leading the Zileuton market?

North America, particularly the United States, and Europe are expected to be the leading regions, with the Asia-Pacific region also showing significant growth[1][3].

What are the key drivers of the Zileuton market?

The key drivers include the increasing prevalence of respiratory diseases, growing reliance on e-commerce and D2C channels, and advances in healthcare infrastructure[1][3].

Who are the major manufacturers of Zileuton ER?

Major manufacturers include Prasco, Chiesi, Lupin, Endo International, and Rising[1].

How much does Zileuton ER cost?

The cost of Zileuton ER can range from around $2,839 for a generic version to $3,968 for the brand name version (Zyflo CR) for a supply of 120 tablets (600 mg each)[2][5].

Sources

1. GitHub - divanaditi/market-analysis: Global Zileuton Market E-Commerce and Direct-to-Consumer, Sustainability.
2. Drugs.com: Zileuton Prices, Coupons, Copay Cards & Patient Assistance.
3. Future Market Insights: Leukotriene Modifiers Market - Share, Size & Forecast 2033.
4. Lupin: Lupin Launches Zileuton Extended-Release Tablets.
5. Drugs.com: Zyflo Prices, Coupons, Copay Cards & Patient Assistance.